Navigation Links
R-Tech Ueno Starts Early Phase II Clinical Trial for RK-023
Date:10/6/2009

s release related July 16, 2009 for more information about the Phase I clinical trial.
  • In a double-blind test, for the purpose of conducting the clinical trial in a completely objective manner, the physicians performing the trial as well as the patients participating in the trial do not know if the substance administered to each individual is the drug being tested or the placebo.
  • The placebo is a substance that does not include the drug being tested (RK-023 in this case).
  • About R-Tech Ueno, Ltd.

    R-Tech Ueno was established in September 1989 for the purpose of marketing and R&D of drugs. Under the leadership of the CEO, also a medical doctor, the company is developing new drugs on the theme "Physician-Oriented New Drug Innovation," targeting ophthalmologic and dermatologic diseases that previously had no effective therapeutic agent. The company's main product Rescula(R) eyedrop 0.12% is a therapeutic drug for glaucoma and ocular hypertension and has been marketed in Japan since 1994. R-Tech Ueno was the first in the world to take advantage of the substance "prostone" in the development of Rescula(R). Prostone was discovered in 1980 by Dr. Ryuji Ueno, the founder of the company. Rescula(R) eyedrop 0.12% that causes less topical and systemic adverse reactions demonstrates steady ocular pressure-decreasing action by twice-a-day instillation. Such excellent therapeutic effects are realized through its optic nerve protection and ocular blood flow-increasing mechanism.

        Stock Code: No.4573, Osaka Securities Exchange; Hercules
        Head Office: 1-1-7 Uchisaiwai-cho, Chiyoda-ku, Tokyo
        Representative Director & President: Yukihiko Mashima
    
    
        Contact:
        Koji Nakamura,
        Business Management Department
        R-Tech Ueno, Ltd.
        Tel: +81-3-3596-8011
        e-mail: koji.nakamura@rtueno.co.jp
        URL: '/>"/>
    SOURCE R-Tech Ueno, Ltd.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
    2. R-Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study of 0.15% UF-021
    3. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
    4. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
    5. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
    6. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
    7. U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
    8. Presbyterian Hospital Dallas Starts Advanced Breast-Cancer Risk-Assessment Program
    9. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
    10. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
    11. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... FRANCISCO, July 31, 2014 Nektar Therapeutics (Nasdaq: ... second quarter ended June 30, 2014. Cash ... $301.4 million as compared to $309.1 million at March 31, ... for Nektar as we look forward to significant milestones for ... Robin, President and Chief Executive Officer of Nektar. "The first ...
    (Date:7/31/2014)... Fla. , July 31, 2014 Rock ... today that it has initiated the development of its ... ; and that it has selected Quotient Clinical, The ... Kingdom (UK) to run its early development ... Clinical Trial Application (CTA) by the end of the ...
    (Date:7/31/2014)... 31, 2014 Touro University California,s College of ... as the recipient of a $150,000 grant by the ... University to increase research and classroom space on its ... for the study of health sciences, and will help ... and interests of our students," said Shelley Berkley ...
    Breaking Medicine Technology:Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 10Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 11Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 12Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 13Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 14Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4Touro University California Garners Grant From Long Foundation 2
    (Date:8/1/2014)... August 01, 2014 St. Christopher's Hospital ... an upcoming episode of Innovations with Ed Begley Jr, ... and show times TBA. , St. Christopher's Hospital for ... for children from birth through 21 years of age. ... of the hospital's specialties, including autism and childhood obesity. ...
    (Date:8/1/2014)... A leading dress supplier, Discount-Dress.com, explores a variety of outfits ... lady’s wardrobe fashionable and exciting. Recently, the company has announced ... attract more people, it is now launching a special offer ... 65% off. , “Summer is the season of short bridesmaid ... our collection of ‘ 2014 summer short styles .’ The ...
    (Date:8/1/2014)... Haelle HealthDay Reporter , THURDAY, ... necessarily healthier than school cafeteria fare, a new study suggests. ... the lunches third and fourth graders brought from home met ... , "Our findings are similar to results of other studies ... found that high-calorie packaged foods and beverages are more common ...
    (Date:8/1/2014)... University] New research shows that people who grew ... have a 16-percent greater risk of experiencing poor health ... member sent to prison. The finding, which accounted for ... high rate of imprisonment may be independently imparting enduring ... "These people were children when this happened, and it ...
    (Date:8/1/2014)... 01, 2014 Fresh from Las Vegas market, ... some new and exciting products. With the 2014 Holiday season ... with some exciting new products. There have already been some ... below, but other brands like Cozzia and Inada will be ... Las Vegas Market takes place two times a year and ...
    Breaking Medicine News(10 mins):Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 2Health News:Innovations with Ed Begley, Jr. to Feature St. Christopher's Hospital for Children in Upcoming Episode 3Health News:Discount-Dress.com’s Top Trend Report: 2014 Summer Short Bridesmaid Dresses Now for Sale 2Health News:Kids' Lunch Boxes Often Fall Short on Nutrition 2Health News:Kids' Lunch Boxes Often Fall Short on Nutrition 3Health News:Jailed family member increases risks for kids' adult health 2Health News:Jailed family member increases risks for kids' adult health 3Health News:A Recap of the 2014 Summer Las Vegas Furniture Market by Emassagechair.com 2Health News:A Recap of the 2014 Summer Las Vegas Furniture Market by Emassagechair.com 3
    ... evaluating their risk for heart disease are missing a crucial ... University of Rochester Medical Center study published in the June ... that most doctors use to assess risk, known as Framingham ... of low income and/or less than a high school education ...
    ... , 2009 marks sixth consecutive year of support , ... Inc. announced today that the company has committed to raise ... Walk." The commitment represents the sixth consecutive year of ... , , "Safety-Kleen is firmly committed to its financial ...
    ... ... ... Sturchio, Chairman, Corporate Council on Africa, and Incoming President, Global Health Council ,Ms. Joan ... Department of State ,Dr. Kate Tulenko, Health Specialist, Coordinator of the Africa Health Workforce ...
    ... 16 The American Association of Oral ... (D-LA) on introducing S. 1235, the Senate companion ... and Surgery (CARES) Act . The bill would require ... Employee Retirement Income Security Act (ERISA) , ...
    ... Provide Personal Guide to Help Local Cancer Patients Better ... , , PHILADELPHIA, June 16 The ... at the Kimmel Cancer Center at Jefferson in Philadelphia, ... is the first site to launch in Pennsylvania as ...
    ... Inventive and Earth-friendly fibers are available to solve customers, needs ... ANSONVILLE, N.C., June 16 "Perpetual Innovation" should bring to ... products but also its process. That,s what Premiere Fibers does. ... www.premierefibers.com as well as a whole ...
    Cached Medicine News:Health News:Income, education, important factors in heart disease risk 2Health News:Safety-Kleen Announces $100,000 Commitment to American Heart Association 'Start! Dallas Heart Walk' 2Health News:Building Healthcare Leadership in Africa: A Call to Action 2Health News:Oral and Maxillofacial Surgeons Applaud Senator Mary Landrieu (D-LA) For Introducing Legislation to Require Insurance Coverage for Children With Congenital Deformities 2Health News:Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 2Health News:Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 3Health News:Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 4Health News:Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 5Health News:Premiere Fibers Unveils New Logo, Names for Innovative Brands 2
    1.0% Casein digest (NZ amine), 0.5% Sodium Chloride....
    0.5% Yeast Extract, 2.0% Tryp, 10mM Sodium Chloride, 2.5mM Potassium Chloride, 10mM Magnesium Chloride, 10mM Mag. Sulfate....
    S.O.C. Medium...
    3.2% Tryptone, 2.0% Yeast Extract, 0.5% Sodium Chloride, pH 7.5....
    Medicine Products: